The market for ‘gene silencing’ therapies is set to explodeDr Dan WilliamsDec 16, 20241 min read Dan Williams discusses the reasons behind this in FirstWord Pharma. Read his analysis here.
In a major article for Drug Discovery World, Dan Williams discussed the opportunities for ASO-based therapies
Commenti